Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL INHALANT
Document Type and Number:
WIPO Patent Application WO/2023/003003
Kind Code:
A1
Abstract:
A novel inhalant is provided as a COVID-19 therapeutic agent. The present invention relates to an inhalant characterized by containing Ivermectin.

Inventors:
OKUMURA MUTSUO (JP)
MURAKAMI SEIICHI (JP)
Application Number:
PCT/JP2022/028139
Publication Date:
January 26, 2023
Filing Date:
July 20, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
KOWA CO (JP)
International Classes:
A61K31/7048; A61K9/14; A61K47/26; A61P31/14
Domestic Patent References:
WO2022034226A12022-02-17
WO2021229514A12021-11-18
WO2021234668A12021-11-25
WO2021247283A12021-12-09
Foreign References:
US20210023111A12021-01-28
JP2009242408A2009-10-22
JP2014224147A2014-12-04
JP2017025106A2017-02-02
Other References:
ANONYMOUS: "Inhaled Ivermectin in the Treatment of SARS-COV-2 (CCOVID-19)", 24 February 2021 (2021-02-24), pages 1 - 7, XP093025045, Retrieved from the Internet [retrieved on 20230217]
CHACCOUR CARLOS, ABIZANDA GLORIA, IRIGOYEN-BARRIO ÁNGEL, CASELLAS AINA, ALDAZ AZUCENA, MARTÍNEZ-GALÁN FERNANDO, HAMMANN FELIX, GIL: "Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats", SCIENTIFIC REPORTS, vol. 10, 1 December 2020 (2020-12-01), pages 1 - 11, XP055963474, DOI: 10.1038/s41598-020-74084-y
Attorney, Agent or Firm:
THE PATENT CORPORATE BODY ARUGA PATENT OFFICE (JP)
Download PDF: